UnknownNot Applicable

Outcomes AlloMap Registry: the Long-term Management and Outcomes of Heart Transplant Recipients With AlloMap Testing

United States2,444 participantsStarted 2013-03

Plain-language summary

The objective of this registry is to observe short and long term clinical outcomes in heart transplant recipients who receive regular AlloMap testing as part of allograft rejection surveillance.

Who can participate

Age range15 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * New and existing heart transplant recipients ≥ 2 months (≥ 55 days) post-transplant receiving post-transplant care at the enrolling centers for interim surveillance monitoring that includes AlloMap testing

What they're measuring

Vital status of heart transplant recipient

Timeframe: 5 Years

Trial details

NCT IDNCT01833195

SponsorCareDx

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2020-02

View on ClinicalTrials.gov More Cardiac Transplant Failure trials